Gene · 4017
Papers2,536
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 2,536
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Inhalation-Based Nanoparticle Drug Delivery Targeting the Diseased Lower Airways in Idiopathic Pulmonary Fibrosis. | Pharmaceutics | 2026 | 41754911 | PubTator, text mining | PubMed |
| Edible Bird's Nest as a Multi-Component Functional Food for Brain Aging: From Single-Bioactive Actions to Network-Regulatory Mechanisms. | Nutrients | 2026 | 41754188 | PubTator, text mining | PubMed |
| The Fibro-Immune Landscape Across Organs: A Single-Cell Comparative Study of Human Fibrotic Diseases. | Int J Mol Sci | 2026 | 41752153 | PubTator, text mining | PubMed |
| Enhancing Cancer Therapy with Hyperthermia: Synergistic Effects with Natural Compounds and Conventional Treatments. | Int J Mol Sci | 2026 | 41751791 | PubTator, text mining | PubMed |
| Reconstructing Liver Fibrosis: 3D Human Models, Microbiome Interfaces, and Therapeutic Innovation. | Curr Issues Mol Biol | 2026 | 41751427 | PubTator, text mining | PubMed |
| New Insights in Respiratory Diseases. | Biomedicines | 2026 | 41751325 | PubTator, text mining | PubMed |
| Percolation Forces in Lung Inflammation: Determining the Path to Emphysema or Fibrosis. | Biomedicines | 2026 | 41751180 | PubTator, text mining | PubMed |
| Piezo1 as a mechanical checkpoint in T cell immunotherapy for solid tumors. | Front Pharmacol | 2026 | 41737555 | PubTator, text mining | PubMed |
| CRMP2 inhibits metastasis formation by impairing ILF3-dependent stabilization of CXCL10 mRNA in breast cancer. | Cell Death Dis | 2026 | 41735286 | PubTator, text mining | PubMed |
| Lysyl Oxidase LOXL2 Selectively Oxidizes Primary, α-Unbranched Amines and Prefers Cationic Substrates. | Biochemistry | 2026 | 41729086 | PubTator, text mining | PubMed |
| Antifibrotic Strategies Targeting Phosphodiesterase-4 in Idiopathic Pulmonary Fibrosis: Molecular Mechanisms and Clinical Translation. | Clin Pharmacol | 2026 | 41726771 | PubTator, text mining | PubMed |
| Protocol to establish glioma stem cell spheroids and an enriched cancer-associated fibroblast population from a single patient tumor specimen. | STAR Protoc | 2026 | 41719131 | PubTator, text mining | PubMed |
| Synergistic effects of radiotherapy and immunotherapy: improving oncological outcomes. | Front Immunol | 2026 | 41716387 | PubTator, text mining | PubMed |
| The signal hijacker: How tumors co-opt chemical, electrical, and mechanical cues to thrive. | Biochim Biophys Acta Rev Cancer | 2026 | 41679351 | PubTator, text mining | PubMed |
| CLIM-TIME identifies metastatic microenvironment modulators for T cell therapy response. | Cell | 2026 | 41679300 | PubTator, text mining | PubMed |
| Small-molecule LOXL2 inhibition as a novel antifibrotic strategy for the treatment of myocardial fibrosis. | Ann Med Surg (Lond) | 2026 | 41675827 | PubTator, text mining | PubMed |
Spatial transcriptomics and single-cell analyses reveal the role of the cisplatin-resistant gene panel in NSCLC progression and the tumor microenvironment, identifying LOXL2 as a potential therapeutic target. | Cancer Cell Int | 2026 | 41673658 | PubTator, text mining | PubMed |
| Transcriptomic analysis reveals the impact of concurrent, resistance, and endurance training on skeletal muscle. | PLoS One | 2026 | 41637404 | PubTator, text mining | PubMed |
| Decoding ECM remodeling: proteases as gatekeepers of Lysyl oxidase family-mediated crosslinking. | FEBS J | 2026 | 41603041 | PubTator, text mining | PubMed |
| Molecular and Immune Mechanisms Governing Cancer Metastasis, Including Dormancy, Microenvironmental Niches, and Tumor-Specific Programs. | Int J Mol Sci | 2026 | 41596524 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4017/papers?page=3